Medicare Drug Price Plan Tramples Constitution, 3rd Circ. Told
By Carla Baranauckas · April 8, 2025, 8:21 PM EDT
New Jersey federal court rulings preserving the Centers for Medicare & Medicaid Services' ability to negotiate prices with drug companies should be overturned on constitutional grounds, pharmaceutical giants Novo Nordisk and...
To view the full article, register now.